Mortality and Parkinson disease: A community based study

Neurology

Volumn 62, Issue 6, 2004, Pages 937-942

  Herlofson, Karen ^a   Lie, Stein Atle ^b   Årsland, Dag ^a   Larsen, Jan P ^a  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

AGED; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NORWAY; ONSET AGE; PARKINSON DISEASE; PATIENT CODING; PRIORITY JOURNAL; PROBABILITY; SURVIVAL RATE; SURVIVAL TIME;

EID: 1842509992     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000115116.56955.50     Document Type: Article

References (31)

1. Hoehn M, Yahr M. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
2. Nobrega FT, Glattre E, Kurland LT, Okazaki H. Comments on the epidemiology of parkinsonism including prevalence and incidence statistics for Rochester, Minnesota, 1935-1966. In: Barbeau A, Brunette JS, eds. Progress in neurogenetics. Amsterdam: Excerpta Medica, 1969:474-485.
3. Hoehn MM. Parkinsonism treated with levodopa: progression and mortality. J Neurol Transm 1983;(suppl 19):253-264.
4. Di Rocco A, Molinari SP, Kollmeier B, Yahr MD. Parkinson's disease: progression and mortality in the 1-dopa era. Adv Neurol 1996;69:3-11.
5. Clarke CE. Does levodopa therapy delay death in Parkinson's disease? A review of the evidence. Mov Disord 1995;10:250-256.
6. Poewe WH, Wenning GK. The natural history of Parkinson's disease. Ann Neurol 1998;44(suppl 1):S1-S9.
7. Scigliano G, Musicco M, Soliveri P, et al. Mortality associated with early and late levodopa therapy initiation in Parkinson's disease. Neurology 1990;40:265-269.
8. Bonifati V, Vanacore N, Bellatreccia A, Meco G. Mortality rates for parkinsonism in Italy (1969 to 1987). Acta Neurol Scand 1993;87:9-13.
9. Chio A, Magnani C, Tolardo G, Schiffer D. Parkinson's disease mortality in Italy, 1951 through 1987. Analysis of an increasing trend. Arch Neurol 1993;50:149-153.
10. Kuopio AM, Marttila RJ, Helenius H, Rinne UK. Changing epidemiology of Parkinson's disease in southwestern Finland. Neurology 1999;52:302-308.
11. Morgante L, Salemi G, Meneghini F, et al. Parkinson disease survival. A population-based study. Arch Neurol 2000;57:507-512.
12. Berger K, Breteler MMB, Helner C, et al. Prognosis with Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurology 2000;54(suppl 5):S24-S27.
13. Lois ED, Marder K, Cote L, Tang M, Mayeux R. Mortality from Parkinson disease. Arch Neurol 1997;54:260-264.
14. Kurtzke JF, Murphy FM. The changing pattern of death rates in parkinsonism. Neurology 1990;40:42-49.
15. Uitti RJ, Ahlskog JE, Maraganore DM, et al. Levodopa therapy and survival in idiopathic Parkinson's disease: Olmstead County project. Neurology 1993;43:1918-1926.
16. Bennett DA, Beckett LA, Murray AM, et al. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med 1996;334:71-76.
17. Morens DM, Davis JW, Grandinetti A, Ross GW, Popper JS, White LR. Epidemiologic observations on Parkinson's disease: incidence and mortality in a prospective study of middle-aged men. Neurology 1996;46:1044-1050.
18. Tandberg E, Larsen JP, Nessler EG, Riise T, Aarli JA. The epidemiology of Parkinson's disease in the county of Rogaland, Norway. Mov Disord 1995;10:541-549.
19. Larsen JP, Dupont E, Tandberg E. The clinical diagnosis of Parkinson's disease: proposal of diagnostic subgroups classified at different levels of confidence. Acta Neurol Scand 1994;84:242-251.
20. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees A. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 1992;42:1142-1146.
21. Fahn S, Elton RL, members of the UPDRS development committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Lieberman A, eds. Recent developments in Parkinson's disease. Florham Park, NJ: MacMillan Health Care Information, 1987:153-163.
22. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
23. Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389.
24. Andersen PK, Borgan Ø, Gill RD, Keiding N. Statistical models based on counting processes. New York: Springer-Verlag, 1993.
25. Dorey FJ, Korn EL. Effective sample size for confidence intervals for survival probabilities. Stat Med 1987;6:679-687.
26. Lie SA, Lie RT, Svanes C. Expected survival compared with survival of peptic ulcer patients. Stat Med 1998;17:1189-1199.
27. Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials 1996;17:343-346.
28. Andersen PK, Væth M. Simple parametric and nonparametric models for excess and relative mortality. Biometrics 1989;45:523-535.
29. Andersen PK, Borch-Johnsen K, Deckert T, et al. A Cox regression model for the relative mortality and its application to diabetes mellitus survival data. Biometrics 1985;41:921-932.
30. Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-752.
31. Beyer MK, Herlofson K, Årsland D, Larsen JP. Causes of death in a community-based study of Parkinson's disease. Acta Neurol Scand 2001;103:7-11.